circomax myco
zoetis belgium - inactivated mycoplasma hyopneumoniae, strain p-5722-3, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (orf2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b orf2 protein - immunologiske stoffer til suidae - svin (slagtekyllinger) - active immunisation of pigs against porcine circovirus type 2 to reduce viral load in blood and lymphoid tissues, fecal shedding and the lesions in lymphoid tissues associated with pcv2 infection. protection was demonstrated against porcine circovirus types 2a, 2b and 2d. active immunisation of pigs against mycoplasma hyopneumoniae to reduce the lung lesions associated with mycoplasma hyopneumoniae infection. onset of immunity (both vaccination schedules): 3 weeks after (the last) vaccination. duration of immunity (both vaccination schedules): 23 weeks after (the last) vaccination. in addition, vaccination has been shown to reduce body weight gain losses under field conditions.
clindamycin "navamedic" 300 mg infusionsvæske, opløsning
navamedic asa - clindamycinphosphat - infusionsvæske, opløsning - 300 mg
alk (552) hesteskæl 10 hep opløsning til priktest (soluprick-sq)
alk-abello a/s - hesteskæl - opløsning til priktest (soluprick-sq) - 10 hep
cefuroxim "b. braun" 750 mg pulver og solvens til infusionsvæske, opløsning
b. braun melsungen - cefuroximnatrium - pulver og solvens til infusionsvæske, opløsning - 750 mg
hyoresp vet. injektionsvæske, suspension
merial norden a/s - mycoplasma hyopneumonia, stamme bq 14 (inaktiveret) - injektionsvæske, suspension - svin
mypravac suis vet. 50 amu injektionsvæske, suspension
laboratorios hipra s.a. - mycoplasma hyopneumonia, stamme j (inaktiveret) - injektionsvæske, suspension - 50 amu - svin
cefuroxim "navamedic" 250 mg pulver til injektions-/infusionsvæske, opløsning
navamedic asa - cefuroxim - pulver til injektions-/infusionsvæske, opløsning - 250 mg
levofloxacin "teva" 5 mg/ml infusionsvæske, opløsning
teva b.v. - levofloxacinhemihydrat - infusionsvæske, opløsning - 5 mg/ml
cefotaxim "mip" 2 g pulver til injektions-/infusionsvæske, opløsning
mip pharma gmbh - cefotaximnatrium - pulver til injektions-/infusionsvæske, opløsning - 2 g
fosfomycin "infectopharm" 40 mg/ml pulver til infusionsvæske, opløsning
infectopharm gmbh - fosfomycinnatrium - pulver til infusionsvæske, opløsning - 40 mg/ml